Erythropoietin-stimulating agent (ESA) dose recovery following hospitalization OF end stage renal disease (ESRD) patients
DownloadSteven Wang, T. Christopher Bond, Jaime Rubin, Alex Yang. Erythropoietin-stimulating agent (ESA) dose recovery following hospitalization of end stage renal disease (ESRD) patients. International Society for Pharmacoeconomics and Outcomes Research. Washington, DC, Jun 2-6, 2012.